Navigation Links
Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results
Date:2/8/2010

CHENGDU, China, Feb. 8 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Alternext: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced fiscal results for its second quarter ended December 31, 2009.

    -- Q2 2010 Revenue Increased 47.9% to $14.9 Million, Net Income Increased
       24.8% to $2.6 Million with adjusted EPS of $0.11 on a diluted basis
    -- Cash and Equivalents of $19.9 Million on December 31, 2009
    -- First-half 2010 Cash Flow from Operations Increased 24.5% to
       $4.9 million
    -- Tianyin secured SFDA approvals for four new products during the second
       quarter addressing multiple indications, bringing total number of
       products in the portfolio to 48


    Q2 FY2010 Results
                                           Q2 FY2010    Q2 FY2009    CHANGE (%)
    Net Sales                           $14.9 million $10.1 million       +48%
    Gross Profit                         $7.8 million  $5.2 million       +50%
    GAAP Net Income                      $2.6 million  $2.1 million       +25%
    Adjusted Net Income*                 $3.4 million  $2.1 million       +62%
    GAAP EPS (Diluted)                        $0.08         $0.13         -38%
    Adjusted EPS (Diluted)                    $0.11         $0.13         -15%
    Weighted Shares Outstanding          30.4 million  15.7 million       +94%

    Six Months FY2010 Results
                                          Six Months    Six Months      CHANGE
                                            FY2010       FY2009           (%)
    Net Sales                           $28.3 million  $19.7 million      +44%
    Gross Profit                        $14.8 million  $10.0 million      +48%
    GAAP Net Income     
'/>"/>
SOURCE  Tianyin Pharmaceutical Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 

Related biology technology :

1. Tianyin Pharmaceutical Co., Inc. Reports Record Fiscal 2009 Financials With $7.9 Million in Net Income
2. Tianyin Pharmaceutical Co., Inc. to Host Fiscal 2009 Earnings Conference Call on Thursday, September 24, 2009 at 10:30 a.m. ET
3. Tianyin Pharmaceutical Co., Inc. Obtains GMP Certification for Its New Production Facility
4. Tianyin Pharmaceutical, Co. to Present at the Rodman & Renshaw Annual Global Investment Conference on September 11 at 10:50 am ET
5. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Sanqi Tablets and Yinqiao Jiedu Tablets
6. Tianyin Pharmaceutical Co., Inc. Announces Cash Dividend to Common Stockholders
7. Tianyin Pharmaceutical Co., Inc. Adopts New Sales Strategy for Azithromycin Dispersible Tablets
8. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Wednesday, February 18, 2009 at 8:45 a.m. EST
9. Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth
10. Tianyin Pharmaceutical Co., Inc. Announces First Quarter 2009 Financial Results
11. Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 20, 2013 With bed bugs' presence come ... although bed bugs need to be eliminated, one must make ... a person's health. And so to help bed bug sufferers ... get rid of bed bugs without using harmful pesticides. ... spray it called Bed Bug Bully. , According to My ...
(Date:5/20/2013)... WOBURN, Mass. , May 20, 2013   ... Frederick W. Driscoll to its ... more than 30 years of financial management experience with ... joining Flexion, Mr. Driscoll was chief financial officer for ... a team that secured more than $250 million through ...
(Date:5/20/2013)... FL (PRWEB) May 20, 2013 Researchers from ... in the connection between lower back pain, and the acne ... P.acnes in the system the bacteria seek out oxygen deprived ... incurred in the spinal column, P.acnes has the ability to ... , Fernando Perez, a spokesman for “ The best ...
(Date:5/20/2013)... Kitware, a leader in data visualization, today ... exploration of hospital costs across the United States ... recent release of “Medicare Provider Charge Data,” a dataset ... from the Centers for Medicare & Medicaid Services. , ... hospitals across the country has sparked considerable controversy; however, ...
Breaking Biology Technology:New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products 2Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer 2Adult Acne Treatment, Probiotic Action Shares New Insight How Treating Acne May Help Reduce Body Pain 2Kitware Enables Interactive Exploration of CMS Medicare Data 2
... Leaders Join Forces to Promote Early Detection ... and Treatment of Hypertension in the UK, ... Ltd. (Tel Aviv Stock Exchange: INCR), and Omron Healthcare (UK),Ltd., ... to strengthen the link between hypertension diagnostics and,therapies in the ...
... Blood found 92 percent reduction in ... incidence ... a rare,blood disorder called PNH experienced a 92 percent reduction ... (eculizumab), according to an analysis of clinical studies,recently published online ...
... 20 - Essential, Structure-Searchable Chemistry ... to Researchers Elsevier Information Systems GmbH, ... of scientific, technical and medical information,is pleased ... the CrossFire Beilstein,database will contain more than ...
Cached Biology Technology:InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom 2InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom 3InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom 4PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 2PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 3PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 4PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 5PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 6PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 7PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 8CrossFire Beilstein Database Exceeds Ten Million Compounds 2CrossFire Beilstein Database Exceeds Ten Million Compounds 3
(Date:5/20/2013)... also commonly resistant to antimicrobial substances made by ... mBio , the online open-access journal of ... and host antimicrobials LL-37 and lysozyme, which help ... that patients with life-threatening multi-drug resistant infections are ... is a last-line drug for treating several kinds ...
(Date:5/20/2013)... Science Foundation (NSF) planning grant will help establish the ... program of the University of Illinois at Urbana-Champaign and ... will be devoted to research in drying moist, porous ... and paper products; chemical products; textiles; and biopharmaceuticals," said ... science and human nutrition and the Illinois site director. ...
(Date:5/19/2013)... a strain of electricity-producing bacteria that can grow using ... dioxide as its sole source of carbon. Researchers ... at the 113th General Meeting of the American Society ... current production solely on hydrogen," says Amit Kumar, a ... are part of the Lovley Lab Group at the ...
Breaking Biology News(10 mins):Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3NSF approves planning grant for Center for Advanced Research in Drying 2
... Fla. (June 16, 2009) To determine if guided ... and functional recovery, researchers at the University of Pittsburgh ... the injured peripheral nerves of laboratory rats. ... shown to be an abundant source of post-natal precursor ...
... engineers have taken a first step toward a minimally ... heat administered from the end of a catheter. ... possible to treat brain tumors without the side effects ... or radiation. The bioengineers designed and built an ...
... University of California, Berkeley, researchers have found what they ... of the puzzle about how stress causes sexual dysfunction ... of stress hormones - glucocorticoids such as cortisol - ... hormone (GnRH), and subsequently suppresses sperm count, ovulation and ...
Cached Biology News:Peripheral nerve repair with fat precursor cells led to wider nerves and less muscle atrophy 2Potential for non-invasive brain tumor treatment 2Stress puts double whammy on reproductive system, fertility 2Stress puts double whammy on reproductive system, fertility 3
... The DNA Engine Dyad instrument is the ... Featuring MJ's world-class thermal performance, the ... display, as well as point-and-click navigation via ... Dyad can be easily and economically expanded ...
...
...
...
Biology Products: